Glaxo Retreats From Medical Ed

Posted by: Arlene Weintraub on September 22, 2009

On September 21, drug giant GlaxoSmithKline announced a major overhaul of its policies for funding the continuing medical education (CME) courses that doctors must take to maintain their licenses. Read more about it on BusinessWeek’s Managing Forward blog.



How can you manage smarter? Bloomberg Businessweek contributors synthesize insights from the brightest business thinkers, critique the latest management trends, and comment on leaders in the news.

BW Mall - Sponsored Links

Buy a link now!